Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Nevirapine pharmacokinetics when initiated at 200 mg or 400 mg daily in HIV-1 and tuberculosis co-infected Ugandan adults on rifampicin, Journal of Antimicrobial Chemotherapy, November 2010, Oxford University Press (OUP),
DOI: 10.1093/jac/dkq411.
You can read the full text:
Contributors
The following have contributed to this page
